Third party research

Administer: Behind the curve, earnings to recover - Evli

This is a third party research report and does not necessarily reflect our views or values

Administer's Q1 missed our estimates, with Silta and EmCe driving the sales shortfall and cost savings yet to fully offset lower volumes on profitability. FY26 guidance and management commentary signal an H2-led recovery.